The table below shows C4 Therapeutics, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
Line item
Q1 2026
Q3 2025
Q2 2025
Q1 2025
Q3 2024
Q2 2024
Revenue
$6.15M
$11.23M
$6.46M
$7.24M
$15.36M
$12.01M
Cost of revenue
-
-
-
-
-
-
Gross profit
-
-
-
-
-
-
R&D
$24.61M
$25.99M
$26.20M
$27.07M
$31.84M
$23.75M
SG&A
CCCC annual revenue (10-K history)
C4 Therapeutics, Inc. reported annual revenue of $35.95M for fiscal year 2025. That is up 1.0% from $35.58M in fiscal 2024. Over the 5 fiscal years shown, annual revenue declined from $45.78M (FY 2021) to $35.95M. Figures come from the company's audited annual reports as filed with the SEC.